BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30843890)

  • 21. Burkitt lymphoma in adults.
    Linch DC
    Br J Haematol; 2012 Mar; 156(6):693-703. PubMed ID: 21923642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
    Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
    Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
    van Imhoff GW; van der Holt B; MacKenzie MA; Ossenkoppele GJ; Wijermans PW; Kramer MH; van 't Veer MB; Schouten HC; van Marwijk Kooy M; van Oers MH; Raemaekers JM; Sonneveld P; Meulendijks LA; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
    Leukemia; 2005 Jun; 19(6):945-52. PubMed ID: 15800666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient].
    Unholzer A; Starz H; Hirschsteiner O; Balda BR
    J Dtsch Dermatol Ges; 2005 Jan; 3(1):46-51. PubMed ID: 16353750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
    Lamar ZS; Fino N; Palmer J; Gruber L; Morris BB; Raetskaya-Solntseva O; Kennedy L; Vaidya R; Hurd D; Zamkoff K
    Clin Lymphoma Myeloma Leuk; 2016 Feb; 16(2):76-81. PubMed ID: 26725264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
    Hashimoto A; Fujimi A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Matsumoto T; Shibata T; Hamaguchi K; Kamihara Y; Iwasaki S; Kato J
    Rinsho Ketsueki; 2015 Jul; 56(7):905-10. PubMed ID: 26256929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult Burkitt leukemia and lymphoma.
    Blum KA; Lozanski G; Byrd JC
    Blood; 2004 Nov; 104(10):3009-20. PubMed ID: 15265787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.
    Xiao J; Du S; Dai G; Gao G; Yang D; Zhao H
    Sci Rep; 2017 May; 7(1):1905. PubMed ID: 28507339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
    J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Burkitt's lymphoma].
    Afanas N; Carvalho M; Almeida M; Costa V; Silva I; Oliva T
    Acta Med Port; 2011; 24(5):735-8. PubMed ID: 22525625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature.
    Quesada AE; Liu H; Miranda RN; Golardi N; Billah S; Medeiros LJ; Jaso JM
    Hum Pathol; 2016 Oct; 56():101-8. PubMed ID: 27257042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posterior Reversible Encephalopathy Syndrome Associated With Dose-adjusted EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy.
    Floeter AE; Patel A; Tran M; Chamberlain MC; Hendrie PC; Gopal AK; Cassaday RD
    Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):225-230. PubMed ID: 28169156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged low intensity EPOCH-rituximab has improved toxicity in Burkitt lymphoma compared with standard short, high intensity therapy.
    Shahbazi S; Peer CJ; Figg WD
    Cancer Biol Ther; 2014 Sep; 15(9):1117-9. PubMed ID: 24919059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkitt lymphoma in adolescents and young adults: management challenges.
    Dozzo M; Carobolante F; Donisi PM; Scattolin A; Maino E; Sancetta R; Viero P; Bassan R
    Adolesc Health Med Ther; 2017; 8():11-29. PubMed ID: 28096698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience.
    Jang SJ; Yoon DH; Kim S; Yoon S; Kim DY; Park CS; Huh J; Lee SW; Lee DH; Ryu JS; Suh C
    Ann Hematol; 2012 Dec; 91(12):1917-22. PubMed ID: 22864762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkitt's lymphoma/leukemia: a clinicopathologic study on 24 adult patients.
    Bernasconi C; Brusamolino E; Pagnucco G; Bernasconi P; Orlandi E; Lazzarino M
    Leukemia; 1991; 5 Suppl 1():90-4. PubMed ID: 1890873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
    Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.